EVOQ Partners With Gilead On NanoDisc Approach To RA, Lupus

Michigan biotech follows 2021 collaboration in autoimmune disease with Amgen with its second tie-up, teaming up with Gilead in rheumatoid arthritis and systemic lupus erythematosus.

Nanotech
EVOQ's approach involves delivering antigens therapeutically via nanotechnology • Source: Shutterstock

More from Deals

More from Business